
Linearis is a life sciences company that leverages AI and biomarkers to prevent, detect, and cure metabolic diseases such as cancers and diabetes. Through its Ventures Fund and Laboratory, Linearis invests in and supports innovative AI-powered life sciences companies. Linearis Labs focuses on identifying multi-omics disease signatures to accelerate the innovation cycle in prevention, treatment monitoring, and AI-driven drug discovery. The company's vision is to accelerate AI innovation to improve health outcomes through novel Omic-AI tests and facilitate drug discovery. They operate with values of responsible innovation, rigor, integrity, collaboration, sustainable impact, and passion for improving people's health.

Linearis is a life sciences company that leverages AI and biomarkers to prevent, detect, and cure metabolic diseases such as cancers and diabetes. Through its Ventures Fund and Laboratory, Linearis invests in and supports innovative AI-powered life sciences companies. Linearis Labs focuses on identifying multi-omics disease signatures to accelerate the innovation cycle in prevention, treatment monitoring, and AI-driven drug discovery. The company's vision is to accelerate AI innovation to improve health outcomes through novel Omic-AI tests and facilitate drug discovery. They operate with values of responsible innovation, rigor, integrity, collaboration, sustainable impact, and passion for improving people's health.